Journal Guide

AJOB Neuroscience and neuroscience.bioethics.net provide a comprehensive resource for scholars, practitioners, and others interested in ethics and the brain sciences. We interpret the scope of the field broadly, and seek wide-ranging contributions exploring the ethical, social and legal dimensions of neuroscience.Our goal is to inspire and inform research and writing across disciplines through target articles, peer commentary, book reviews, qualitative research, and other innovative formats. As a primary resource in the field, neuroscience.bioethics.net publishes announcements, career opportunities, and the latest news and developments in the discipline.

ASN Neuro is an open access, peer-reviewed journal uniquely positioned to provide investigators with the most recent advances across the breadth of the cellular and molecular neurosciences. The official journal of the American Society for Neurochemistry, ASN Neuro is dedicated to the promotion, support, and facilitation of communication among cellular and molecular neuroscientists of all specializations. The open access platform and comprehensive scope of the journal allow for rapid dissemination of current research across disciplines to contribute to a complete approach to issues pertaining to the nervous system. High-quality research articles and reviews in such areas as neurochemistry and biology, neurogenetics, glial cells and function, neurodevelopment, neurodegeneration and repair, neuroimmunity, signaling, and other neuro- or glial-related topics are encouraged for submission. There is no charge for submitting a paper to ASN Neuro. Upon acceptance of your manuscript, you will be charged a one-time Article Processing Charge (APC). This fee covers the cost of publication and ensures that your article will be freely available.

Acta Neurologica Scandinavica aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental work in neuroscience. The journla's scope is to act as an international forum for the dissemination of information advancing the science or practice of this subject area. Papers in English will be welcomed, especially those which bring new knowledge and observations from the application of therapies or techniques in the combating of a broad spectrum of neurological disease and neurodegenerative disorders. Relevant articles on the basic neurosciences will be published where they extend present understanding of such disorders. Priority will be given to review of topical subjects. Papers requiring rapid publication because of their significance and timeliness will be included as 'Clinical commentaries' not exceeding two printed pages, as will 'Clinical commentaries' of sufficient general interest. Debate within the speciality is encouraged in the form of 'Letters to the editor'. All submitted manuscripts falling within the overall scope of the journal will be assessed by suitably qualified referees. Submit your manuscript online.

Acta Neuropathologica´s mission is to publish the best articles on pathology and pathogenesis of neurological disease. The journal focuses on structural and molecular neuropathology using human tissue, animal models and in vitro systems.

The journal publishes Original Papers, Review Articles, Case Reports and Scientific Correspondence.

Six reasons for publishing your best paper in Acta Neuropathologica:

High impact: 9.730 (IF 2012)

Wide distribution: more than 6,000 institutions worldwide having full text access.

Efficient handling: 12 days between submission and first decision.

Fast publication: 10 days between acceptance and online publication.

Commitment to fairness: author feedback program.

Cost-free printing: no page charges - free color figures.

Acta Neuropathologica Communications publishes experimental and descriptive papers on the pathology of nervous system and skeletal muscle disorders and on mechanisms of neurological disease using morphological, molecular and cell biology methods.

Acta Neuropsychiatrica is an international journal that publishes high-quality research papers in neuropharmacology neuropsychiatry and neuroscience. The journal provides a forum for original basic and clinical research from disciplines and research areas relevant to the pathophysiology, neurobiology, and treatment of neuropsychiatric disorders. Acta Neuropsychiatrica provides its readership with the latest perspectives from current and emerging fields of psychiatry, neurology, pharmacology, genetics and neuroimaging. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques/strategies. Emphasis will be given to original research that is of wide interest and clearly advances the field.

Adaptive Behavior is a highly ranked, international peer reviewed journal that publishes original research and review articles on adaptive behavior in living organisms and autonomous artificial systems.For over 17 years it has offered ethologists, psychologists, behavioral ecologists, computer scientists, neuroscientists and robotics researchers a forum for discussing new findings and comparing insights and approaches across disciplines. The journal explores mechanisms, organizational principles, and architectures that can be expressed in computational, physical, or mathematical models related to the both the functions and dysfunctions of adaptive behavior.The journal publishes articles, reviews, short communications, target articles and commentaries addressing challenges in the cognitive and behavioral sciences and including topics such as perception and motor control, embodied cognition, learning and evolution, neural mechanisms, action selection and behavioral sequences, motivation and emotion, characterization of environments, decision making, collective and social behavior, navigation, foraging, communication and signalling.

Advances in Autism (AIA) builds and disseminates evidence on the health and care aspects and outcomes of autistic people, with the goal to inform researchers and professionals; improving the quality of life for those living on the autistic spectrum.

As the average human life expectancy has increased, so too has the impact of ageing and age-related disease on our society. Ageing research is now the focus of thousands of laboratories that include leaders in the areas of genetics, molecular and cellular biology, biochemistry, and behaviour. Ageing Research Reviews (ARR) covers the trends in this field. It is designed to fill a large void, namely, a source for critical reviews and viewpoints on emerging findings on mechanisms of ageing and age-related disease. Rapid advances in understanding of mechanisms that control cellular proliferation, differentiation and survival are leading to new insight into the regulation of ageing. From telomerase to stem cells to energy and oxyradical metabolism, this is an exciting new era in the multidisciplinary field of ageing research. The cellular and molecular underpinnings of manipulations that extend lifespan, such as caloric restriction, are being identified and novel approaches for preventing age-related diseases are being developed. ARR publishes articles on focussed topics selected from the broad field of ageing research, with an emphasis on cellular and molecular mechanisms of the aging process and age-related diseases such as cancer, cardiovascular disease, diabetes and neurodegenerative disorders. Applications of basic ageing research to lifespan extension and disease prevention are also covered in this journal.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Alcohol is an international, peer-reviewed journal that is devoted to publishing multi-disciplinary biomedical research on all aspects of the actions or effects of alcohol on the nervous system or on other organ systems. Emphasis is given to studies into the causes and consequences of alcohol abuse and alcoholism, and biomedical aspects of diagnosis, etiology, treatment or prevention of alcohol-related health effects.

Frontiers in Life Science publishes high quality, innovative research at the frontier of biology with an emphasis on interdisciplinary research at the interface between the life sciences and the more quantitative sciences. Disclaimer Taylor & Francis make every effort to ensure the accuracy of all the information (the 'Content') contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.

The mission of Alzheimer's & Dementia: Journal of the Alzheimer's Association is to bridge the knowledge gaps across a wide range of bench-to-bedside investigation. The journal publishes the results of studies in: behavior, biochemistry, genetics, molecular biology, pharmacology, physiology, protein chemistry, neurology, neuropathology, psychiatry, geriatrics, neuropsychology, epidemiology, sociology, health services research, health economics, political science and public policy. Content emphasizes interdisciplinary investigations, integrative/translational articles, related to: etiology, risk factors, early detection, disease modifying interventions, prevention of dementia and applications of new technologies in health services. The journal publishes • comprehensive reviews; • research articles; • information on clinical trials; • short reports;• in-depth perspectives/open-peer commentaries; • theoretical and/or translational papers that attempt integrate knowledge across discipline;• history & politics of science/brief biographies and, • abstracts of papers presented at international meetings. Negative results, particularly clinical trials, are published as short communications.The ultimate objective is to create a novel forum for: • rapid communication of new findings, ideas or perspectives; • disseminating knowledge, across the spectrum of basic to clinical studies, necessary for optimal translation of research findings into practical applications/interventions; • integrating knowledge across disciplines; • increase knowledge in diverse disciplines to promote early detection/diagnosis and/or interventions; • formulating new theories and/or strategies for the rigorous testing of theories or their predictions; • identifying promising new directions of research and, • providing the scientific impetus for new initiatives; or public policies concerning research on prevention and new models of health services.Alzheimer's & Dementia is indexed/abstracted in Index Medicus/MEDLINE, Scopus, Science Citation Index Expanded (SciSearch®), Current Contents®/Clinical Medicine, Neuroscience Citation Index®, and Journal Citation Reports/Science Edition.

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports. Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.

The American Journal of Alzheimer's Disease and Other Dementias® (AJADD) is for and by professionals on the frontlines of Alzheimer's care, dementia, and clinical depression--especially physicians, nurses, psychiatrists, healthcare administrators, and other related healthcare specialists who deal with patients having dementias and families everyday. In every issue, you will find down-to-earth clinical information on * Practical medical, psychiatric, and nursing issues such as assessment and management of problem behaviors, communication difficulties, dealing with delusions and other psychotic features, apathy, effects of physical activity, integrated treatment approaches, new and changing pharmacotherapies, orientation behaviors, and hospice use. AJADD also includes information on management of concurrent medical issues in the patient with dementia. * New and forthcoming diagnostic tools such as computerized testing for mild cognitive impairment and other aspects of cognitive testing, as well as high technology resources for sophisticated disease characterization. AJADD also provides information on the clinical features and management of non-Alzheimer's dementias. * Psychosocial issues such as dealing with staff caregivers' distress, improving caregivers' communication skills, helping patients and families to deal with a diagnosis of Alzheimer's disease or another dementia, and patients' perceptions and preferences. * Practice-oriented clinical research from the frontiers of neurology and genetics, including sleep-wake states, targeting glutamate excitotoxicity, cholesterol and apolipoprotein E, and other aspects of the underlying biology that causes the symptoms of dementia. AJADD also reports on the latest clinical trials that focus on medications for the symptoms of dementia and the disease process. * Administrative and legal issues such as coding, consumer evaluation of adult day-care services, cost-effectiveness of special care units, dangerous wandering, end-stage dementia, informed consent, Medicare coverage for cognitively impaired residents, supervision of high-risk fall dementia patients, and vulnerable populations and avoidable hospitalizations.By 2025, it is estimated that there will be about 34 million people in the world with some form of Alzheimer's disease or other dementia. To stay ahead of the latest research, clinical practices and procedures, and administrative issues, subscribe to the American Journal of Alzheimer's Disease and Other Dementias® today!Read the American Journal of Alzheimer's Disease and Other Dementias® call for papers.

Neuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG) , provides a forum for experimental and clinical investigations of the genetic mechanisms underlying neurologic and psychiatric disorders. It is a resource for novel genetics studies of the heritable nature of psychiatric and other nervous system disorders, characterized at the molecular, cellular or behavior levels. Neuropsychiatric Genetics publishes eight times per year.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is an exciting new initiative. It represents a timely expansion of the journal Amyotrophic Lateral Sclerosis in response to the clinical, imaging pathological and genetic overlap between ALS and frontotemporal dementia. The expanded journal provides outstanding coverage of research in a wide range of issues related to motor neuron diseases, especially ALS (Lou Gehrig’s disease) and cognitive decline associated with frontotemporal degeneration. The journal also covers related disorders of the neuroaxis when relevant to these core conditions. The Editorial Board comprises key opinion leaders in ALS and FTD. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration aims to disseminate information on new developments in the pathogenesis and management of ALS and FTD, and enhance awareness of these devastating and often under-recognised disorders.